Startseite > Produktkatalog > Biowissenschaften > Nukleosid > β-D-erythro-Pentofuranuronic acid, 3,3′-[(1,20-dioxo-1,20-eicosanediyl)diimino]bis[1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, 5,5′-dimethyl ester (ACI)
[CAS No.1434288-40-0] A1253725 β-D-erythro-Pentofuranuronic acid, 3,3′-[(1,20-dioxo-1,20-eicosanediyl)diimino]bis[1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, 5,5′-dimethyl ester (ACI) 97%
Katalognummer:
Cas No.:
Summenformel:
Molekulargewicht:
MDL No:
EINECS:
Bestellung/Angebotsanfrage/Technischer Support
Telefon: 0086-571-89925085
bestellen & Anfrage: sales@amadischem.com
technischer Support: tech@amadischem.com
*Alle Chemikalien unseres Unternehmens sind nur für den Labor- und Produktionsgebrauch bestimmt.
Basisinformationen [1434288-40-0]
Synonyme:
Aussehen:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Lageranforderungen:
Pubchem ID:
Smiles:
Inchi:
InchiKey:
Sicherheitsinformationen [1434288-40-0]
Piktogramm:
Signalwort:
UN No.:
Gefahrenkategorie:
Verpackungsklasse:
Gefahrenhinweise:
Sicherheitshinweise:
Verwandte Literatur [1434288-40-0]
Es tut uns leid, keine entsprechende Literatur
Ähnliche Produkte [1434288-40-0]
β-D-erythro-Pentofuranuronamide, C-3-amino-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-1,2,3-trideoxy-1-thymin-1-yl-, thymin-1-yl = 3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl (ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, 3-amino-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, ethyl ester (9CI, ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, 3-[[(2S)-2-amino-1-oxopropyl]amino]-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, methyl ester (ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, C-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-β-D-erythro-pentofuranuronoylimino-(5→3)-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, methyl ester (ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, C-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-β-D-erythro-pentofuranuronoylimino-(5→3)-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, methyl ester (ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, 3-[[3-amino-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-β-D-erythro-pentofuranuronoyl]amino]-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, methyl ester (ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, 1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-β-D-erythro-pentofuranuronoyl]amino]-, methyl ester (ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, 1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester (ACI)
Reason:Nukleosid
β-D-erythro-Pentofuranuronic acid, 1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-, 5,5′-(1,12-dodecanediyl) ester (ACI)
Reason:Nukleosid
Produktdetails [1434288-40-0]
Es tut uns leid, keine Produktdetails verfügbar
Browserverlauf
Es tut uns leid, kein Browserverlauf
wettbewerbsfähige Preise
effiziente Logistik
technischer Support
ausreichende Lagerbestände